Jeffrey R. Baxter
2021
In 2021, Jeffrey R. Baxter earned a total compensation of $3.5M as President, Chief Executive Officer at VBI Vaccines, a 54% increase compared to previous year.
Compensation breakdown
| Bonus | $367,813 |
|---|---|
| Option Awards | $2,410,000 |
| Salary | $605,000 |
| Other | $67,409 |
| Total | $3,450,222 |
Baxter received $2.4M in option awards, accounting for 70% of the total pay in 2021.
Baxter also received $367.8K in bonus, $605K in salary and $67.4K in other compensation.
Rankings
In 2021, Jeffrey R. Baxter's compensation ranked 3,882nd out of 12,406 executives tracked by ExecPay. In other words, Baxter earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,882 out of 12,406 | 69th |
Division Manufacturing | 1,590 out of 5,492 | 71st |
Major group Chemicals And Allied Products | 651 out of 2,368 | 73rd |
Industry group Drugs | 579 out of 2,089 | 72nd |
Industry Pharmaceutical Preparations | 405 out of 1,536 | 74th |
Source: SEC filing on April 29, 2022.
Baxter's colleagues
We found two more compensation records of executives who worked with Jeffrey R. Baxter at VBI Vaccines in 2021.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019